| Name | Title | Contact Details |
|---|
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III
Avecia is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Avecia is based in Milford, MA. You can find more information on Avecia at www.avecia.com
OnHealth Network Company is an independent source of consumer-oriented health and wellness information, products and services on the Web. The Company's website, onhealth.com, is a consumer-focused online health destination dedicated to the management of
Nursefinders of Indianapolis is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Arkansas-based Beverly (NYSE: BEV) operates 351 nursing homes, 18 assisted living centers and 52 hospice and home health centers.